The application of nanotechnology in medicine: treatment and diagnostics

Andrew Owain; Christine Dufès; Davide Moscatelli; Eric Mayes; Jonathan Lovell; Kattesh Katti; Konstantin Sokolov; Mariarosa Mazza; Olivier Fontaine; Steve Rannard; Vicki  Stone

doi:10.2217/nnm.14.93

The application of nanotechnology in medicine: treatment and diagnostics

Andrew Owain, Christine Dufès, Davide Moscatelli, Eric Mayes, Jonathan Lovell, Kattesh Katti, Konstantin Sokolov, Mariarosa Mazza, Olivier Fontaine, Steve Rannard, Vicki Stone

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

Abstract

The British Society for Nanomedicine (BSNM) [1], in collaboration with SELECTBIO, organized Nanomedicine 2014. BSNM is a registered charity created to allow open access for industry, academia, clinicians and the public to news and details of ongoing nanomedicine research. The Nanomedicine 2014 program provided insight across a number of emerging nanotechnologies spanning treatment to diagnostics. A key objective of the meeting was provision of opportunities to build collaborations and rationalize nanoenabled healthcare solutions.

Original language	English
Pages (from-to)	1291-1294
Number of pages	4
Journal	Nanomedicine
Volume	9
Issue number	9
DOIs	https://doi.org/10.2217/nnm.14.93
Publication status	Published - 31 Jul 2014
Event	Nanomedicine 2014 - Edinburgh, United Kingdom Duration: 26 Mar 2014 → 27 Mar 2014

Keywords

nanotechnology
nanomedicine
nanomedicine research

Access to Document

10.2217/nnm.14.93

Cite this

@article{d32c524e47cf42cd9dc3c9c7bd237396,

title = "The application of nanotechnology in medicine: treatment and diagnostics",

abstract = "The British Society for Nanomedicine (BSNM) [1], in collaboration with SELECTBIO, organized Nanomedicine 2014. BSNM is a registered charity created to allow open access for industry, academia, clinicians and the public to news and details of ongoing nanomedicine research. The Nanomedicine 2014 program provided insight across a number of emerging nanotechnologies spanning treatment to diagnostics. A key objective of the meeting was provision of opportunities to build collaborations and rationalize nanoenabled healthcare solutions.",

keywords = "nanotechnology, nanomedicine, nanomedicine research",

author = "Andrew Owain and Christine Duf{\`e}s and Davide Moscatelli and Eric Mayes and Jonathan Lovell and Kattesh Katti and Konstantin Sokolov and Mariarosa Mazza and Olivier Fontaine and Steve Rannard and Vicki Stone",

year = "2014",

month = jul,

day = "31",

doi = "10.2217/nnm.14.93",

language = "English",

volume = "9",

pages = "1291--1294 ",

journal = "Nanomedicine",

issn = "1743-5889",

number = "9",

note = "Nanomedicine 2014 ; Conference date: 26-03-2014 Through 27-03-2014",

}

TY - JOUR

T1 - The application of nanotechnology in medicine

T2 - Nanomedicine 2014

AU - Owain, Andrew

AU - Dufès, Christine

AU - Moscatelli, Davide

AU - Mayes, Eric

AU - Lovell, Jonathan

AU - Katti, Kattesh

AU - Sokolov, Konstantin

AU - Mazza, Mariarosa

AU - Fontaine, Olivier

AU - Rannard, Steve

AU - Stone, Vicki

PY - 2014/7/31

Y1 - 2014/7/31

N2 - The British Society for Nanomedicine (BSNM) [1], in collaboration with SELECTBIO, organized Nanomedicine 2014. BSNM is a registered charity created to allow open access for industry, academia, clinicians and the public to news and details of ongoing nanomedicine research. The Nanomedicine 2014 program provided insight across a number of emerging nanotechnologies spanning treatment to diagnostics. A key objective of the meeting was provision of opportunities to build collaborations and rationalize nanoenabled healthcare solutions.

AB - The British Society for Nanomedicine (BSNM) [1], in collaboration with SELECTBIO, organized Nanomedicine 2014. BSNM is a registered charity created to allow open access for industry, academia, clinicians and the public to news and details of ongoing nanomedicine research. The Nanomedicine 2014 program provided insight across a number of emerging nanotechnologies spanning treatment to diagnostics. A key objective of the meeting was provision of opportunities to build collaborations and rationalize nanoenabled healthcare solutions.

KW - nanotechnology

KW - nanomedicine

KW - nanomedicine research

U2 - 10.2217/nnm.14.93

DO - 10.2217/nnm.14.93

M3 - Article

SN - 1743-5889

VL - 9

SP - 1291

EP - 1294

JO - Nanomedicine

JF - Nanomedicine

IS - 9

Y2 - 26 March 2014 through 27 March 2014

ER -

The application of nanotechnology in medicine: treatment and diagnostics

Abstract

Keywords

Access to Document

Fingerprint

Cite this